150 related articles for article (PubMed ID: 9219485)
1. Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results.
Oliaro A; Filosso PL; Bello M; Casadio C; Angusti T; Masaneo I; Maggi G; Bisi G
J Cardiovasc Surg (Torino); 1997 Jun; 38(3):313-5. PubMed ID: 9219485
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary results on the use of scintigraphy with radiolabelled octreotide as diagnostic method in neuroendocrine and nonendocrine neoplasms of the lung].
Oliaro A; Filosso PL; Bellò M; Casadio C; Muni A; Angusti T; Masaneo I; Bisi G; Maggi G
Minerva Chir; 1997 Nov; 52(11):1335-8. PubMed ID: 9489331
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine carcinomas of the lung and role of 111In-DTPA-octreotide scintigraphy: preliminary results.
Oliaro A; Filosso PL; Bello M; Casadio C; Muni A; Greco B; Bertuccio G; Bisi G; Maggi G
J Cardiovasc Surg (Torino); 1996 Dec; 37(6):653-6. PubMed ID: 9016988
[TBL] [Abstract][Full Text] [Related]
4. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
[TBL] [Abstract][Full Text] [Related]
5. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
[TBL] [Abstract][Full Text] [Related]
6. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
7. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.
Srirajaskanthan R; Kayani I; Quigley AM; Soh J; Caplin ME; Bomanji J
J Nucl Med; 2010 Jun; 51(6):875-82. PubMed ID: 20484441
[TBL] [Abstract][Full Text] [Related]
8. [Role of somatostatin analogs in the treatment of neuroendocrine tumours].
Cuccurullo V; Cascini GL; Rambaldi PF; Mansi L
Minerva Endocrinol; 2001 Sep; 26(3):135-43. PubMed ID: 11753236
[TBL] [Abstract][Full Text] [Related]
9. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Banzo J; Abós MD; Prats E; García F; Razola P
Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
[No Abstract] [Full Text] [Related]
10. Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview.
Kwekkeboom DJ; Krenning EP
Eur Radiol; 1997; 7(7):1103-9. PubMed ID: 9265684
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
Bombardieri E; Crippa F; Cataldo I; Chiti A; Seregni E; Soresi E; Boffi R; Invernizzi G; Buraggi GL
Eur J Cancer; 1995; 31A(2):184-8. PubMed ID: 7718323
[TBL] [Abstract][Full Text] [Related]
12. Influence of tumour size and uptake of 99mTc-octreotide on radio-guided surgery for neuroendocrine tumors.
Hodolic M; Fettich J; Rubello D
Minerva Endocrinol; 2009 Jun; 34(2):89-96. PubMed ID: 19471233
[TBL] [Abstract][Full Text] [Related]
13. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
[TBL] [Abstract][Full Text] [Related]
14. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer.
Vaccarili M; Lococo A; Fabiani F; Staffilano A
Tumori; 2000; 86(3):224-8. PubMed ID: 10939603
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor imaging.
Kwekkeboom DJ; Krenning EP
Semin Nucl Med; 2002 Apr; 32(2):84-91. PubMed ID: 11965603
[TBL] [Abstract][Full Text] [Related]
16. Radio-guided surgery in neuroendocrine tumors.
Gulec SA; Baum R
J Surg Oncol; 2007 Sep; 96(4):309-15. PubMed ID: 17726664
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.
Hubalewska-Dydejczyk A; Fröss-Baron K; Mikołajczak R; Maecke HR; Huszno B; Pach D; Sowa-Staszczak A; Janota B; Szybiński P; Kulig J
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1123-33. PubMed ID: 16721571
[TBL] [Abstract][Full Text] [Related]
19. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.
Frilling A; Malago M; Martin H; Broelsch CE
Surgery; 1998 Dec; 124(6):1000-4. PubMed ID: 9854575
[TBL] [Abstract][Full Text] [Related]
20. 111In-octreotide scintigraphy in small cell lung cancer.
Semprebene A; Ferraironi A; Franciotti G; Venturo I; Giunta S; Lopez M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
